Decreasing Trend in Mortality of Chronic Myelogenous Leukemia Patients After Introduction of Imatinib in Japan and the U.S.

PURPOSE. Although the impact of imatinib in improving survival outcomes in chronic myelogenous leukemia (CML) patients has been widely reported, its impact on mortality from CML has not been evaluated. A survival benefit demonstrated in clinical trials does not simply translate to a decrease in mort...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chihara, Dai, Ito, Hidemi, Matsuda, Tomohiro, Katanoda, Kota, Shibata, Akiko, Saika, Kumiko, Sobue, Tomotaka, Matsuo, Keitaro
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2012
Assuntos:
Leukemias
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3528387/
https://ncbi.nlm.nih.gov/pubmed/22971523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0197
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados